Coppell Advisory Solutions’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,086
Closed -$202K 229
2025
Q4
$202K Buy
+2,086
New +$203K 0.02% 384
2025
Q1
Sell
-2,095
Closed -$167K 1230
2024
Q4
$167K Buy
2,095
+248
+13% +$21.5K 0.02% 313
2024
Q3
$165K Sell
1,847
-450
-20% -$37.9K 0.02% 320
2024
Q2
$181K Buy
+2,297
New +$188K 0.03% 274
2023
Q4
$184K Buy
2,236
+1,432
+178% +$109K 0.04% 275
2023
Q3
$62.5K Sell
804
-79
-9% -$6.61K 0.02% 270
2023
Q2
$76.6K Buy
+883
New +$76K 0.02% 300
2023
Q1
Sell
-804
Closed -$62.5K 714
2022
Q4
$62.5K Buy
+804
New +$65.2K 0.02% 274

Other funds holding MDT

Coppell Advisory Solutions's MDT Position: Q1 2026 in Review

Coppell Advisory Solutions sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,086 shares — an estimated $202K sold.

Coppell Advisory Solutions first reported a position in MDT in Q4 2022 and held it in 8 quarters. The position peaked at $202K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Coppell Advisory Solutions reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Coppell Advisory Solutions sold 2,086 Medtronic shares in Q1 2026, an estimated $202K.
  • Coppell Advisory Solutions first reported a position in Medtronic in Q4 2022 and held it in 8 quarters.
  • Coppell Advisory Solutions's Medtronic position peaked at $202K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Coppell Advisory Solutions's 13F filing for Q1 2026, filed 15 May 2026.